Business Context and Reporting Period
This Form 8-K is a current report filed by ADVENTRX Pharmaceuticals, Inc. (not Savara Inc.) on October 16, 2009. The filing addresses a corporate governance event involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial data.
Material Changes
- Director Resignation: On October 16, 2009, Alexander J. Denner resigned as a director of the Company and from all Board committees, effective immediately.
- Reason for Departure: The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Dr. Denner's resignation.
- Confirm whether the Company has initiated a search for a replacement director.
- Review subsequent filings for any undisclosed disagreements or related party transactions involving the departing director.